Pfizer is betting big on cancer drugs after Covid decline
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a…
New pet drugs are looking a lot more like human medications
Monty Rakusen | Digitalvision | Getty Images If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to look…
Pfizer RSV vaccine protects older adults over two seasons
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer’s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an…
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable market, rivals are still eager to join the race. Bank…
Viking Therapeutics weight loss drug shows promising trial results
Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 90% on Tuesday after the company’s experimental weight loss drug showed promising initial results in a mid-stage…
Why we would be considering buying more Eli Lilly shares if they were down
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday…
Medicare drug price negotiations: Judge tosses PhRMA lawsuit
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker…
Novo Nordisk, Eli Lilly are tackling supply issues
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss…
Pfizer (PFE) Q4 earnings report 2023
Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business loss less revenue than expected. The company reversed roughly $3.5 billion in revenue related to…
GSK posts blowout RSV vaccine sales, raises outlook
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Dado Ruvic | Reuters GlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit…